- <![CDATA[RAPNO Criteria and MRI Assessment in PLGG: Recommendations vs. Real-World Practice]]><![CDATA[Learn how clinicians weigh symptoms, MRI changes and family goals to decide when a child’s tumor needs treatment—beyond simple size cutoffs.]]>onclive · 2mo ago↗ source
- <![CDATA[ctDNA in Metastatic Urothelial Carcinoma]]><![CDATA[Experts explain how ctDNA tracking in metastatic cancer helps tailor immunotherapy, spot relapse early, and guide dose breaks—plus key limitations.]]>onclive · 2mo ago↗ source
- <![CDATA[Institutional Perspectives on Treatment Thresholds in PLGG]]><![CDATA[Experts weigh PLGG treatment choices, balancing chemo and MEK inhibitors, guided by vision decline, symptoms, tumor growth, and family logistics.]]>onclive · 2mo ago